Courtney L. Scaife,
MD
Vice-Chair for Cancer Affairs in Surgery, Department of Surgery; Chief, Section of Surgical Oncology, Division of General Surgery
Languages Spoken: English
Dr. Courtney Scaife is a Professor of Surgery at the University of Utah who specializes in the care of patients requiring surgical treatment related to gastrointestinal oncology. Dr. Scaife earned her undergraduate degree from DePauw University and medical degree from the University of Wisconsin. Her general surgery residency was done at the University of Utah which was followed by a two-year fellowship in surgical oncology at the University of Texas MD Anderson Cancer Center. Dr. Scaife joined the faculty at the University of Utah in 2003 and is a tenured academic surgeon. Dr. Scaife’s focus in surgery involves diseases of the liver, pancreas, and gastrointestinal tract. Her clinical efforts include both complex surgical endeavors as well as academic research. She has received numerous research grants and participates with other colleagues in the areas of diagnosis and treatment of cancer, in particular pancreatic cancer.
Dr. Scaife was appointed as the Vice-Chair for Cancer Affairs in Surgery representing the Department of Surgery at the Huntsman Cancer Institute. She is the Chief for the Section of Surgical Oncology in the Division of General Surgery. Additionally, she serves as the Gastrointestinal Disease Center Leader at the Huntsman Cancer Institute.
Clinical Locations
Clinic 2B, GI Oncology
801-585-0250
Fax: (801) 585-3846
General Surgery, Area E
801-585-6911
Fax: (801) 585-3749
Specialties
- Liver, Biliary, & Pancreas Surgery
- Colorectal Surgery
- Esophageal Surgery
- Gastric/Esophageal Surgery
- Oncology Surgery
- Soft Tissue Sarcoma Surgery
- Minimally Invasive Gastrointestinal Surgery
- Sarcoma
- Surgery, General
- Gastrointestinal Stromal Tumors
- Upper Gastrointestinal Tract Surgery
- Pancreatic Cancer
Board Certification and Academic Information
| Academic Departments | Surgery
-
Professor |
| Academic Divisions | General Surgery |
| Board Certification | American Board of Surgery (Sub: General Surgery) |
Patient Rating
The Patient Rating score is an average of all responses to care provider related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
Likelihood of recommending care provider
4.8/ 5
Care provider's explanation of condition/problem
4.8/ 5
Care provider's effort to include me in decisions
4.8/ 5
Wait time at clinic
4.5/ 5
Care provider's concern for questions & worries
4.8/ 5
Patient Comments
Patient comments are gathered from our Press Ganey Patient Satisfaction Survery and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.
UofU Patient
November 07, 2021
HUNTSMAN CANCER CENTER
They are all great
UofU Patient
October 31, 2021
HUNTSMAN CANCER CENTER
Awesome
UofU Patient
October 19, 2021
HUNTSMAN CANCER CENTER
Dr. Scaife was wonderful and her staff. Heard a lot of good things about her and we're thankful she will be our surgeon
UofU Patient
October 10, 2021
HUNTSMAN CANCER CENTER
Great
UofU Patient
September 13, 2021
HUNTSMAN CANCER CENTER
Everything was handled by a joint effort of teams .
UofU Patient
August 17, 2021
HUNTSMAN CANCER CENTER
Took great care of me. Great staff.
UofU Patient
July 30, 2021
HUNTSMAN CANCER CENTER
Dr Scaife and all her resident and student were EXCELLENT. I received excellent care. I would (and have) recommend them highly to anyone.
UofU Patient
June 09, 2021
HUNTSMAN CANCER CENTER
very limited options - no mention of quality of life afterwards. Apparently i am not a good candidate for procedure due to prior habits, which is disappointing.
UofU Patient
May 25, 2021
HUNTSMAN CANCER CENTER
None
UofU Patient
May 08, 2021
HUNTSMAN CANCER CENTER
Everything was easy.
UofU Patient
April 25, 2021
HUNTSMAN CANCER CENTER
I have never met with a doctor that had researched and provided the information that Doctor Scaife provided. I left there totally informed and satisfied from the information she provided. Thank you Dr. Scaife.
UofU Patient
April 20, 2021
HUNTSMAN CANCER CENTER
the best hospital ever
UofU Patient
April 11, 2021
HUNTSMAN CANCER CENTER
Courtney Scaife and her team are the best.
UofU Patient
March 13, 2021
HUNTSMAN CANCER CENTER
Dr. Scaife has shown great empathy and concern for me throughout my case and has been willing to spend as much time as needed to explain things.
UofU Patient
March 07, 2021
HUNTSMAN CANCER CENTER
dr Scaife is excellent
UofU Patient
February 21, 2021
HUNTSMAN CANCER CENTER
I couldn't be more pleased with everyone at the hospital and institute. You literally saved my life, and I will be forever grateful.
UofU Patient
February 21, 2021
HUNTSMAN CANCER CENTER
Dr Scaife took the time to answer all my questions. She explained everything very clearly.
UofU Patient
February 21, 2021
HUNTSMAN CANCER CENTER
Left the call not knowing anything but that they got the cancer. no explination of what I was and wasn't supposed to do or how long until I can go back to work.
UofU Patient
February 15, 2021
HUNTSMAN CANCER CENTER
The diagnosis was their decision and they really didn't ask us about what we wanted to do or options with chemo
UofU Patient
January 19, 2021
HUNTSMAN CANCER CENTER
Again, I was amazed by the genuine concern and professionalism every member of my "Dream Team" has shown.
UofU Patient
January 12, 2021
HUNTSMAN CANCER CENTER
Dr. Scaife is very personable and knowledgeable. I trust her professional opinion and always enjoy my visits. She seems to genuinely care
UofU Patient
January 12, 2021
HUNTSMAN CANCER CENTER
Dr Scaif and the resident who first saw me were great. Explained things clearly
UofU Patient
December 22, 2020
HUNTSMAN CANCER CENTER
very kind and thorough doctor. both Dr Scaife and Soares. and the intern. all excellent.
UofU Patient
October 19, 2020
HUNTSMAN CANCER CENTER
I wish I could have been informed earlier
UofU Patient
October 06, 2020
HUNTSMAN CANCER CENTER
The Doctor let me make the decision regarding my treatment.
UofU Patient
September 15, 2020
HUNTSMAN CANCER CENTER
I doubt that I will ever be in a position to recommend this very specialized care, but I have no reservation about the quality.
UofU Patient
September 15, 2020
HUNTSMAN CANCER CENTER
they don't call my wife to inform her all the procedures
UofU Patient
September 07, 2020
HUNTSMAN CANCER CENTER
Easy to understand and Kindness come to mind
UofU Patient
August 28, 2020
HUNTSMAN CANCER CENTER
I felt like the dr. and staff were very thorough and clear about what the diagnosis and treatment would be. Felt confident in the plan of action.
UofU Patient
August 10, 2020
HUNTSMAN CANCER CENTER
Dr. Scaife is the BEST!!
UofU Patient
August 05, 2020
HUNTSMAN CANCER CENTER
Dr Scaiffe and team are awesome.
UofU Patient
August 03, 2020
HUNTSMAN CANCER CENTER
Dr.Scaife tought me alot about my body
UofU Patient
July 29, 2020
HUNTSMAN CANCER CENTER
Very satisfied with concern and care.
UofU Patient
July 01, 2020
HUNTSMAN CANCER CENTER
my only minor comment is I thought the sample was taken straight into the fat pad. I realized after taking off thick dressing the bruising went left and right past ncision for several inches. I wasn't expecting so much bruising but all in all the procedure went great
UofU Patient
July 01, 2020
HUNTSMAN CANCER CENTER
Very personable Doctor. She made me feel very comfortable discussing my issues.
UofU Patient
June 29, 2020
HUNTSMAN CANCER CENTER
Dr. Scaife was very attentive and caring as well as knowledgeable and helpful.
UofU Patient
June 24, 2020
HUNTSMAN CANCER CENTER
I had never had this procedure before, so the information was very helpful and appreciated.
UofU Patient
June 12, 2020
HUNTSMAN CANCER CENTER
I always get the utmost in professional, knowledgeable, and friendly care from Dr. Scaife and her staff. Dr. Scaife is very easy to talk to and discuss my medical care. She always explains the situation in terms that are understandable. I am very happy and pleased with Dr. Scaife, and her staff's care.
UofU Patient
May 27, 2020
HUNTSMAN CANCER CENTER
Dr. Scaife is one of the best specialists I have had the chance to have care for me. I recommend her to everyone that could benefit from her brilliance.
UofU Patient
May 26, 2020
HUNTSMAN CANCER CENTER
Dr. Scaife was very attentive and took more time with me than i expected. Very thourough.
UofU Patient
May 20, 2020
HUNTSMAN CANCER CENTER
She took her time and was very thorough!
UofU Patient
May 11, 2020
HUNTSMAN CANCER CENTER
The care given to my husband has been exceptional.
UofU Patient
March 04, 2020
UH HOSPITALS AND CLINICS
lol good
UofU Patient
March 04, 2020
HUNTSMAN CANCER CENTER
She was Very kind explained everything to me in details you could tell she wanted me to know all the information I would recommend her to anyone.
UofU Patient
March 01, 2020
HUNTSMAN CANCER CENTER
Dr. Scaife was amazing. She had reviewed my records in detail before the appointment. She did a fantastic job of explaining things.
UofU Patient
February 24, 2020
UH HOSPITALS AND CLINICS
excellente experience
UofU Patient
February 04, 2020
UH HOSPITALS AND CLINICS
Care and timeliness was great. I would warn others about the horrible parking only. Everything else was top-notch.
Dr. Courtney Scaife is a Professor of Surgery at the University of Utah who specializes in the care of patients requiring surgical treatment related to gastrointestinal oncology. Dr. Scaife earned her undergraduate degree from DePauw University and medical degree from the University of Wisconsin. Her general surgery residency was done at the University of Utah which was followed by a two-year fellowship in surgical oncology at the University of Texas MD Anderson Cancer Center. Dr. Scaife joined the faculty at the University of Utah in 2003 and is a tenured academic surgeon. Dr. Scaife’s focus in surgery involves diseases of the liver, pancreas, and gastrointestinal tract. Her clinical efforts include both complex surgical endeavors as well as academic research. She has received numerous research grants and participates with other colleagues in the areas of diagnosis and treatment of cancer, in particular pancreatic cancer.
Dr. Scaife was appointed as the Vice-Chair for Cancer Affairs in Surgery representing the Department of Surgery at the Huntsman Cancer Institute. She is the Chief for the Section of Surgical Oncology in the Division of General Surgery. Additionally, she serves as the Gastrointestinal Disease Center Leader at the Huntsman Cancer Institute.
Academic Locations
Board Certification and Academic Information
| Academic Departments | Surgery
-
Professor |
| Academic Divisions | General Surgery |
| Board Certification | American Board of Surgery (Sub: General Surgery) |
Research Interests
- Pancreatic Cancer
- Pancreatic Neoplasms
- Genotype
- Carcinoma, Islet Cell
- Cell Line, Tumor
- Clinical Outcomes
- Stromal Cells
Education History
| Fellowship | University of Texas MD Anderson Cancer Center Oncology Fellow, 2003 |
| Residency | University of Utah School of Medicine General Surgery Resident, 2001 |
| Internship | University of Utah School of Medicine General Surgery Intern, 1996 |
| Professional Medical | University of Wisconsin School of Medicine Medicine M.D., 1995 |
| Undergraduate | DePauw University B.S., 1990 |
Selected Publications - Journal Articles
Journal Article
- Affolter KE, Hellwig S, Nix DA, Bronner MP, Thomas A, Fuertes CL, Hamil CL, Garrido-Laguna I, Scaife CL, Mulvihill SJ, Underhill HR (2021). Detection of circulating tumor DNA without a tumor-informed search using next-generation sequencing is a prognostic biomarker in pancreatic ductal adenocarcinoma. Neoplasia, 23(9), 859-869.
- Bleicher J, Lambert LA, Scaife CL, Colonna A (2021). Current management of malignant bowel obstructions: a survey of acute care surgeons and surgical oncologists. Trauma Surg Acute Care Open, 6(1), e000755.
- Swords DS, Scaife CL (2020). Decompositions of the Contribution of Treatment Disparities to Survival Disparities in Stage I-II Pancreatic Adenocarcinoma. Ann Surg Oncol, 28(6), 3157-3168.
- Swords DS, Scaife CL (2020). ASO Author Reflections: Using Causal Mediation Analysis to Understand the Proportion of Survival Disparities Mediated by Potentially Modifiable Treatment Factors. Ann Surg Oncol, 28(6), 3169-3170.
- Eisele Y, Mallea PM, Gigic B, Stephens WZ, Warby CA, Buhrke K, Lin T, Boehm J, Schrotz-King P, Hardikar S, Huang LC, Pickron TB, Scaife CL, Viskochil R, Koelsch T, Peoples AR, Pletneva MA, Bronner M, Schneider M, Ulrich AB, Swanson EA, Toriola AT, Shibata D, Li CI, Siegel EM, Figueiredo J, Janssen KP, Hauner H, Round J, Ulrich CM, Holowatyj AN, Ose J (2021). Fusobacterium nucleatum and Clinicopathologic Features of Colorectal Cancer: Results From the ColoCare Study. Clin Colorectal Cancer, 20(3), e165-e172.
- Bleicher J, Cohan JN, Huang LC, Peche W, Pickron TB, Scaife CL, Bowles TL, Hyngstrom JR, Asare EA (2020). Trends in the management of anorectal melanoma: A multi-institutional retrospective study and review of the world literature. World J Gastroenterol, 27(3), 267-280.
- Swords DS, Mulvihill SJ, Brooke BS, Stoddard GJ, Firpo MA, Scaife CL (2019). County-level Variation in Use of Surgery and Cancer-specific Survival for Stage I-II Pancreatic Adenocarcinoma. Ann Surg, 272(6), 1102-1109.
- Stokes SM, Scaife CL, Brooke BS, Glasgow RE, Mulvihill SJ, Finlayson SRG, Varghese TK Jr (2020). Hospital Costs Following Surgical Complications: A Value-driven Outcomes Analysis of Cost Savings Due to Complication Prevention. Ann Surg.
- Geijsen AJMR, Ulvik A, Gigic B, Kok DE, van Duijnhoven FJB, Holowatyj AN, Brezina S, van Roekel EH, Baierl A, Bergmann MM, Bhm J, Bours MJL, Brenner H, Breukink SO, Bronner MP, Chang-Claude J, de Wilt JHW, Grady WM, Grnberger T, Gumpenberger T, Herpel E, Hoffmeister M, Huang LC, Jedrzkiewicz JD, Keulen ETP, Kiblawi R, Klsch T, Koole JL, Kosma K, Kouwenhoven EA, Kruyt FM, Kvalheim G, Li CI, Lin T, Ose J, Pickron TB, Scaife CL, Schirmacher P, Schneider MA, Schrotz-King P, Singer MC, Swanson ER, van Duijvendijk P, van Halteren HK, van Zutphen M, Vickers K, Vogelaar FJ, Wesselink E, Habermann N, Ulrich AB, Ueland PM, Weijenberg MP, Gsur A, Ulrich CM, Kampman E (2020). Circulating Folate and Folic Acid Concentrations: Associations With Colorectal Cancer Recurrence and Survival. JNCI Cancer Spectr, 4(5), pkaa051.
- Swords DS, Mulvihill SJ, Brooke BS, Firpo MA, Scaife CL (2019). Size and Importance of Socioeconomic Status-Based Disparities in Use of Surgery in Nonadvanced Stage Gastrointestinal Cancers. Ann Surg Oncol, 27(2), 333-341.
- Swords DS, Scaife CL (2019). ASO Author Reflections: Socioeconomic Disparities in Use of Surgery for Gastrointestinal Cancers Are Large and Impactful in Poor-Prognosis Cancers. Ann Surg Oncol, 27(2), 342-343.
- Bleicher J, Shepherd HM, Scaife CL (2020). Hemoglobin A1c as a marker to stratify diabetes risk following pancreaticoduodenectomy. Surg Open Sci, 2(3), 136-139.
- Varedi D, Frigerio A, Scaife C, Hull C (2019). A novel case of TIF1 gamma autoantibody positive dermatomyositis associated with a non-functional pancreatic neuroendocrine tumor. Dermatol Online J, 25(3).
- Shen Y, Zificsak CA, Shea JE, Lao X, Bollt O, Li X, Lisko JG, Theroff JP, Scaife CL, Ator MA, Ruggeri BA, Dorsey BD, Kuwada SK (2015). Design, synthesis, and biological evaluation of sulfonyl acrylonitriles as novel inhibitors of cancer metastasis and spread. J Med Chem, 58(3), 1140-58.
- Russell KW, Scaife CL, Weber DC, Windsor JS, Wheeler AR, Smith WR, Wedmore I, McIntosh SE, Lieberman JR (2014). Wilderness Medical Society practice guidelines for the treatment of acute pain in remote environments: 2014 update. Wilderness Environ Med, 25(4 Suppl), S96-104.
- Bowen ME, Mone MC, Nelson EW, Scaife CL (2014). Image-guided placement of long-term central venous catheters reduces complications and cost. Am J Surg, 208(6), 937-41; discussion 941.
- Chen Y, Youn P, Pysher TJ, Scaife CL, Furgeson DY (2014). Tumour eradication using synchronous thermal ablation and Hsp90 chemotherapy with protein engineered triblock biopolymer-geldanamycin conjugates. Int J Hyperthermia, 30(8), 550-64.
- Martin P, Noonan S, Mullen MP, Scaife C, Tosetto M, Nolan B, Wynne K, Hyland J, Sheahan K, Elia G, ODonoghue D, Fennelly D, OSullivan J (2014). Predicting response to vascular endothelial growth factor inhibitor and chemotherapy in metastatic colorectal cancer. BMC Cancer, 14, 887.
- Benson AB 3rd, DAngelica MI, Abrams TA, Are C, Bloomston PM, Chang DT, Clary BM, Covey AM, Ensminger WD, Iyer R, Kelley RK, Linehan D, Malafa MP, Meranze SG, Park JO, Pawlik T, Posey JA, Scaife C, Schefter T, Sigurdson ER, Tian GG, Vauthey JN, Venook AP, Yen Y, Zhu AX, Hoffmann KG, McMillian NR, Sundar H (2014). Hepatobiliary cancers, version 2.2014. J Natl Compr Canc Netw, 12(8), 1152-82.
- Kendrick ZW, Firpo MA, Repko RC, Scaife CL, Adler DG, Boucher KM, Mulvihill SJ (2014). Serum IGFBP2 and MSLN as diagnostic and prognostic biomarkers for pancreatic cancer. HPB (Oxford), 16(7), 670-6.
- Jackson KL, Glasgow RE, Mone MC, Sheng X, Mulvihill SJ, Scaife CL (2014). Does travel distance influence length of stay in elective pancreatic surgery? HPB (Oxford), 16(6), 543-9.
- Russell KW, Scaife CL, Weber DC, Windsor JS, Wheeler AR, Smith W, Wedmore I, McIntosh SE, Lieberman JR (2014). Wilderness Medical Society practice guidelines for the treatment of acute pain in remote environments. Wilderness Environ Med, 25(1), 41-9.
- Scaife CL, Hewitt KC, Mone MC, Hansen HJ, Nelson ET, Mulvihill SJ (2014). Comparison of intraoperative versus delayed enteral feeding tube placement in patients undergoing a Whipple procedure. HPB (Oxford), 16(1), 62-9.
- Nelson ET, Gross ME, Mone MC, Hansen HJ, Nelson EW, Scaife CL (2013). A survey of American College of Surgery fellows evaluating their use of antibiotic prophylaxis in the placement of subcutaneously implanted central venous access ports. Am J Surg, 206(6), 1034-9; discussion 1039-40.
- Scaife CL, Hartz A, Pappas L, Pelletier P, He T, Glasgow RE, Mulvihill SJ (2013). Association between postoperative complications and clinical cancer outcomes. Ann Surg Oncol, 20(13), 4063-6.
- Russell KW, Mone MC, Scaife CL (2013). Umbilical paracentesis for acute hernia reduction in cirrhotic patients.LID - 10.1136/bcr-2013-201304 [doi]LID - bcr2013201304 [pii]. BMJ Case Rep, 2013.
- Witt BL, Kristen Hilden RN, Scaife C, Chadwick B, Layfield L, Cory Johnston W, Safaee M, Siddiqui A, Adler DG (2013). Identification of factors predictive of malignancy in patients with atypical biliary brushing results obtained via ERCP. Diagn Cytopathol, 41(8), 682-8.
- Poruk KE, Gay DZ, Brown K, Mulvihill JD, Boucher KM, Scaife CL, Firpo MA, Mulvihill SJ (2013). The clinical utility of CA 19-9 in pancreatic adenocarcinoma: diagnostic and prognostic updates. Curr Mol Med, 13(3), 340-51.
- Poruk KE, Firpo MA, Scaife CL, Adler DG, Emerson LL, Boucher KM, Mulvihill SJ (2013). Serum osteopontin and tissue inhibitor of metalloproteinase 1 as diagnostic and prognostic biomarkers for pancreatic adenocarcinoma. Pancreas, 42(2), 193-7.
- Jackson KL, Glasgow RE, Hill BR, Mone MC, Sklow B, Scaife CL, Sheng X, Peche WJ (2013). Does travel distance influence length of stay in elective colorectal surgery? Dis Colon Rectum, 56(3), 367-73.
- Rapoport N, Payne A, Dillon C, Shea J, Scaife C, Gupta R (2013). Focused ultrasound-mediated drug delivery to pancreatic cancer in a mouse model. J Ther Ultrasound, 1, 11.
- Chen LL, Chen X, Choi H, Sang H, Chen LC, Zhang H, Gouw L, Andtbacka RH, Chan BK, Rodesch CK, Jimenez A, Cano P, Jones KA, Oyedeji CO, Martins T, Hill HR, Schumacher J, Willmore C, Scaife CL, Ward JH, Morton K, Randall RL, Lazar AJ, Patel S, Trent JC, Frazier ML, Lin P, Jensen P, Benjamin RS (2012). Exploiting antitumor immunity to overcome relapse and improve remission duration. Cancer Immunol Immunother, 61(7), 1113-24.
- Hazard L, Jones K, Shaban A, Anker C, Scaife C, Weis J, Mulvihill S (2012). Prospective phase I study of capecitabine and oxaliplatin concurrent with radiation therapy for the treatment of locally advanced pancreatic adenocarcinoma, and retrospective comparison to concurrent 5-fluorouracil/radiation and gemcitabine/radiation. J Gastrointest Cancer, 43(2), 258-66.
- Pearson EG, Scaife CL, Mulvihill SJ, Glasgow RE (2012). Roux-en-Y drainage of a pancreatic fistula for disconnected pancreatic duct syndrome after acute necrotizing pancreatitis. HPB (Oxford), 14(1), 26-31.
- Gross ME, Nelson ET, Mone MC, Hansen HJ, Sklow B, Glasgow RE, Scaife CL (2011). A comparison of postoperative outcomes utilizing a continuous preperitoneal infusion versus epidural for midline laparotomy. Am J Surg, 202(6), 765-9; discussion 770.
- Rapoport N, Nam KH, Gupta R, Gao Z, Mohan P, Payne A, Todd N, Liu X, Kim T, Shea J, Scaife C, Parker DL, Jeong EK, Kennedy AM (2011). Ultrasound-mediated tumor imaging and nanotherapy using drug loaded, block copolymer stabilized perfluorocarbon nanoemulsions. J Control Release, 153(1), 4-15.
- Kennedy SA, Scaife C, Dunn MJ, Wood AE, Watson RW (2011). Benefits of heat treatment to the protease packed neutrophil for proteome analysis: halting protein degradation. Proteomics, 11(12), 2560-4.
- Shea JE, Nam KH, Rapoport N, Scaife CL (2011). Genexol inhibits primary tumour growth and metastases in gemcitabine-resistant pancreatic ductal adenocarcinoma. HPB (Oxford), 13(3), 153-7.
- Kopinke D, Brailsford M, Shea JE, Leavitt R, Scaife CL, Murtaugh LC (2011). Lineage tracing reveals the dynamic contribution of Hes1+ cells to the developing and adult pancreas. Development, 138(3), 431-41.
- Scaife CL, Gross ME, Mone MC, Hansen HJ, Litz CL, Nelson ET, Anderson CJ, Wagner G, Gawlick U, Nelson EW (2010). Antibiotic prophylaxis in the placement of totally implanted central venous access ports. Am J Surg, 200(6), 719-22; disussion 722-3.
- Poruk KE, Firpo MA, Huerter LM, Scaife CL, Emerson LL, Boucher KM, Jones KA, Mulvihill SJ (2010). Serum platelet factor 4 is an independent predictor of survival and venous thromboembolism in patients with pancreatic adenocarcinoma. Cancer Epidemiol Biomarkers Prev, 19(10), 2605-10.
- Scaife CL, Shea J, Emerson L, Boucher K, Firpo MA, Beckerle MC, Mulvihill SJ (2010). Prognostic significance of PINCH signalling in human pancreatic ductal adenocarcinoma. HPB (Oxford), 12(5), 352-8.
- Deer EL, Gonzlez-Hernndez J, Coursen JD, Shea JE, Ngatia J, Scaife CL, Firpo MA, Mulvihill SJ (2010). Phenotype and genotype of pancreatic cancer cell lines. Pancreas, 39(4), 425-35.
- Rapoport N, Kennedy AM, Shea JE, Scaife CL, Nam KH (2010). Ultrasonic nanotherapy of pancreatic cancer: lessons from ultrasound imaging. Mol Pharm, 7(1), 22-31.
Editorial
- Swords DS, Scaife CL (2021). Granular neighborhood-level socioeconomic data: An opportunity for a different kind of precision oncology? Am J Surg, 222(1), 8-9.
- Scaife C (2019). SWSC 2019 Presidential address "Putting Patients First". Am J Surg, 218(6), 1035-1039.
Other
The Scope & Other Podcasts
- Overwhelmed with Information on Colorectal Cancer Treatment? Talk to Your Doctor
- Do You Need a Whipple Procedure? All About the Surgery and Life Afterward
- Do You Need Surgery for Barrett’s Esophagus?
- Pancreas Cancer - The Tumor Stroma Interaction - Courtney Scaife, MD and Jill Shea, MD - 11/16/11
- Courtney Scaife